MyAverix Finance
KQ · Healthcare
Rznomics (476830)
Biotechnology
Rznomics (476830) is listed on KQ in the Healthcare sector. Industry: Biotechnology. As of 2026-05-19, reported market cap is $1.91T, P/E ratio is 18.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 476830
Rznomics (476830) — FAQ
What is Rznomics's market cap?
Rznomics (476830) has a reported market cap of $1.91T (data as of 2026-05-19).
What is 476830's P/E ratio?
The price-to-earnings (P/E) ratio for Rznomics (476830) is 18.00 (data as of 2026-05-19).
Does Rznomics pay a dividend?
Dividend yield is not available in the current snapshot for Rznomics (476830). Check the MyAverix Finance app for the latest dividend data.
What sector is Rznomics in?
Rznomics (476830) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 476830 listed on?
476830 is listed on KQ.
What is Rznomics's net margin?
Rznomics (476830) reports a net margin of 0.0% (data as of 2026-05-19).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.